RVMD
Revolution Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$210.02
−0.40%0
Insider buys (3m)
57
Insider sells (3m)
-$65.8M
Net value (3m)
+39.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 12,919 | $202 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 2,128 | $205 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 7,271 | $204 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 26,160 | $204 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 6,597 | $201 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 300 | $201 |
| Sep 2, 2026 | Kim Lorence H. · director | Sale | 625 | $206 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 245 | $211 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | Sale | 3,400 | $207 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 126 | $210 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 3,621 | $212 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | M-Exempt | 80,000 | $4.73 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | Sale | 2,540 | $210 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | Sale | 3,314 | $212 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | M-Exempt | 26,600 | $22 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 127 | $212 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 6,583 | $211 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 951 | $208 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | M-Exempt | 29,680 | $19 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 24,917 | $208 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 190 | $207 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 35,938 | $209 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 177 | $207 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 5,128 | $207 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 3,813 | $210 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | Sale | 17,323 | $208 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 229 | $211 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 1,405 | $209 |
| Aug 25, 2026 | Cislini Jeff · officer: General Counsel | Sale | 4,500 | $211 |
| Aug 25, 2026 | GOLDSMITH MARK A · director, officer: See Remarks | Sale | 937 | $208 |
Institutional positioning
13F filings over the trailing two quarters
New 420Increased 410Reduced 288Sold out 62
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13,695,790 | Aug 7, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 13,604,796 | May 15, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 13,550,796 | Aug 14, 2026 |
| FMR LLC | Increased | 12,200,422 | Aug 13, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 11,443,357 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 11,212,706 | May 13, 2026 |
| Jupiter Topco LLC | New Position | 10,736,145 | Aug 14, 2026 |
| Darwin Global Management, Ltd. | Increased | 10,629,822 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 9,766,496 | May 18, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 9,555,357 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 9,088,661 | Aug 13, 2026 |
| FMR LLC | Reduced | 8,464,314 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 8,362,284 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 8,294,855 | Aug 13, 2026 |
| NEXTECH INVEST, LTD. | Unchanged | 7,601,087 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026